Germany reportedly drafts a plan to hit US tech, drug supplies and companies, Bloomberg reports citing sources; officials are mapping vulnerabilities in US supply chains to apply pressure on the US

Germany's reported plan to target US tech and drug supplies signals a significant escalatory move in trade tensions, particularly as it aims to exploit vulnerabilities in US supply chains. This could lead to increased volatility in affected sectors and prompt a re-evaluation of international supply dynamics, impacting investment strategies across markets. Market participants should stay alert for any retaliative measures from the US and the potential implications for risk sentiment.